Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 50 and up

Comparing different doses of triamcinolone for knee osteoarthritis pain relief

Official title: The Efficacy of Intra-articular Triamcinolone Acetonide 5mg vs. 10 mg vs. 40 mg in Patients With Knee Osteoarthritis: a Non-inferiority Randomized Controlled Double-blind Study

Run by Centre hospitalier de l'Université de Montréal (CHUM) · NCT05806021 · Data updated 2026-11-12

This study is testing different doses of a knee injection to see which one helps people with knee osteoarthritis pain the most while causing the least side effects.

More Gonarthrosis trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages50 Years and up
SexAll
Enrollment327 (estimated)
SponsorCentre hospitalier de l'Université de Montréal (CHUM)
Academic / other
Locations1 site (Montreal, Quebec)
StatusRecruiting
StartedJanuary 15, 2024
Main results expectedDecember 2025
Study endsFebruary 2026
Registry record updatedFebruary 5, 2025
Trial IDNCT05806021 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals aged 60 and older with symptomatic primary gonarthrosis lasting over six months and moderate knee pain.

Probably not a fit

Patients with advanced osteoarthritis (Grade 4) or those who have received recent corticosteroid injections may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the efficacy of three different doses of intra-articular triamcinolone acetonide (5mg, 10mg, and 40mg) in patients suffering from knee osteoarthritis. The study aims to determine the optimal dose that provides effective pain relief while minimizing potential side effects associated with corticosteroid injections. Participants will be assessed based on their knee pain levels and the severity of their osteoarthritis, following established criteria. The trial is designed to provide clearer guidance on corticosteroid dosing for knee osteoarthritis management.

Why it matters

Potential benefit: If successful, this study could lead to more effective and safer treatment options for patients with knee osteoarthritis.

How similar studies have gone: Previous studies have shown varying success with corticosteroid injections for knee osteoarthritis, but this specific dose comparison is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Symptomatic primary gonarthrosis of over 6 months duration (gonarthrosis according to the American College of Rheumatology criteria)
* Grade 1 to 3 Kellgren-Lawrence femorotibial osteoarthritis
* Knee pain provoked by activity over 4 and under 8 on 10 (Visual Analog Scale)

Exclusion Criteria:

* Bilateral symptomatic primary gonarthrosis
* Grade 4 Kellgren-Lawrence femorotibial osteoarthritis
* Isolated patellofemoral osteoarthritis
* Intra-articular corticosteroid infiltration to the knee within the past 3 months or chronic use of per os corticosteroid
* Intra-articular hyaluronic acid infiltration within the past 12 months.
* Intra-articular infiltration of platelet-rich plasma within the past 12 months.
* Disease affecting the study joint (systemic inflammatory disease, history of septic arthritis, osteonecrosis, etc.).
* Suspicion or presence of active local infectious process.
* Presence or suspicion of local neoplasia or metastasis
* Recent severe trauma to the knee (≤ 3 months)
* Significant cognitive impairment or inadequate language proficiency not allowing adequate response to study questionnaires
* Any other serious medical condition that does not allow participation in the study or may be a contraindication to cortisone injection

Where it's running

  • Centre Hospitalier Universitaire de Montréal - Hôtel-Dieu
    Montreal, Quebec, Canada
    Recruiting

Study contacts

  • Principal investigator: Dien Hung Luong, MD — Centre hospitalier de l'Université de Montréal (CHUM)
  • Study coordinator: Dien Hung Luong, MD
  • Email: dh.luong79@gmail.com
  • Phone: 5148908000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.